Skip to main content

Table 1 Clinical and demographic characteristics of all individuals included in the study

From: Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients

Groups

Age (Years) Mean ± SD

Gender - n (%)

PVL

Spasticity in lower limbs

Overactive bladder

F

M

Median (IQR 25–75)

n (%)

n (%)

HAM/TSP (n = 20)

48.7 ± 10

13 (65.0)

7 (35.0)

173,146 (94,232-240,393)*

20 (100)

13 (76)a

AS (n = 28)

42.9 ± 11.4

19 (67.9)

9 (32.1)

10,101 (1659-36,326)

0

0

CTR (n = 18)

41.4 ± 14.2

10 (55.6)

8 (44.4)

0

0

  1. HAM/TSP HTLV-1-associated myelopathy/Tropical spastic paraparesis, AS Asymptomatic, CTR Uninfected controls, n Number, SD Standard Deviation, F Female, M Male, IQR Interquartile range, PVL HTLV-1 Proviral load (copies/106 PBMC), performed for 14 patients with HAM/TSP and 24 asymtomatic individuals. aData available from only 17 HAM/TSP patients. Statistical analysis of differences between groups determined by the Kruskal-Wallis test, followed by Dunn’s post-test. Statistical analysis of proviral load performed using the Mann-Whitney test. *(p = 0.0001)